Sector consensus Repligen Corporation
Stocks
RGEN
US7599161095
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Cboe BZX
15:56:46 2026-09-14 EDT
|
5-day change | 1st Jan Change | ||
| 168.68 USD | +2.12% |
|
-0.87% | +1.95% |
| 09-09 | Repligen Corporation Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-09-2026 01:30 PM | |
| 09-09 | UBS Adjusts Price Target on Repligen to $225 From $195, Keeps Buy Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 189.48 | +14.71% | 21 | ||||||
| 120.26 | +17.96% | 25 | ||||||
| 104.76 | +15.17% | 25 | ||||||
| 369.31 | +14.85% | 13 | ||||||
| 30,600 | +34.86% | 15 | ||||||
| 195.67 | +10.02% | 12 | ||||||
| 94.12 | +13.36% | 25 | ||||||
| 44.6 | +37.1% | 25 | ||||||
| 405.38 | +17.08% | 16 | ||||||
| 3,140.77 | +39.84% | 13 | ||||||
| 235.5 | +26% | 14 | ||||||
| 263.12 | +24.85% | 8 | ||||||
| 107.57 | +15.06% | 21 | ||||||
| 93.92 | +7.4% | 13 | ||||||
| 43.95 | +1.84% | 11 | ||||||
| 28.73 | +20.7% | 11 | ||||||
| 208.6 | +38.31% | 15 | ||||||
| 14.66 | -1.01% | 15 | ||||||
| 103.23 | +39.14% | 13 | ||||||
| 329 | -10.92% | 5 | ||||||
| Average | 1,834.63 | +18.82% | 16 | ||||||
| Weighted average by Cap. | 2,373.15 | +18.82% | 19 |
- Stock Market
- Stocks
- RGEN Stock
- Sector Repligen Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
